NZ318843A - Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine - Google Patents

Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine

Info

Publication number
NZ318843A
NZ318843A NZ318843A NZ31884396A NZ318843A NZ 318843 A NZ318843 A NZ 318843A NZ 318843 A NZ318843 A NZ 318843A NZ 31884396 A NZ31884396 A NZ 31884396A NZ 318843 A NZ318843 A NZ 318843A
Authority
NZ
New Zealand
Prior art keywords
alkyl
preparing
compound
formula
indanon
Prior art date
Application number
NZ318843A
Inventor
Keith M Devries
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ318843A publication Critical patent/NZ318843A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

he present invention relates to a process for preparing a compound of formula (I) above, wherein R1 is R2O(C=O)- or R3(C=O)-, R2 is (C1-C4)alkyl, and R3 is (C1-C4)alkyl or phenyl optionally substituted with from one to three substituents independently selected from (C1-C4)alkyl, (C1-C4)alkoxy, halo or trifluoromethyl, comprising: a) reacting a compound of formula (III), wherein R1 is R2O(C=O)- or R3(C=O)-, R2 is (C1-C4)alkyl, and R3 is (C1-C4)alkyl or phenyl optionally substituted with from one to three substituents independently selected from (C1-C4)alkyl, (C1-C4)alkoxy, halo or trifluoromethyl, with a methenylation agent to form a compound of formula (II) as disclosed; and b) reacting said compound of formula (II) as disclosed, so formed, with a strong acid.
NZ318843A 1995-12-15 1996-10-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine NZ318843A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US875395P 1995-12-15 1995-12-15
PCT/IB1996/001076 WO1997022584A1 (en) 1995-12-15 1996-10-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine

Publications (1)

Publication Number Publication Date
NZ318843A true NZ318843A (en) 2000-01-28

Family

ID=21733469

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ318843A NZ318843A (en) 1995-12-15 1996-10-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine

Country Status (33)

Country Link
EP (1) EP0883607A1 (en)
JP (1) JP3066083B2 (en)
KR (1) KR20000064387A (en)
AP (1) AP708A (en)
AR (1) AR004368A1 (en)
AU (1) AU716462B2 (en)
BG (1) BG102525A (en)
BR (1) BR9612018A (en)
CA (1) CA2237647A1 (en)
CO (1) CO4750831A1 (en)
CZ (1) CZ180898A3 (en)
DZ (1) DZ2141A1 (en)
GT (1) GT199600092A (en)
HN (1) HN1996000065A (en)
HR (1) HRP960592A2 (en)
HU (1) HUP9904275A3 (en)
IL (3) IL136421A0 (en)
IS (1) IS4752A (en)
MA (1) MA24032A1 (en)
NO (1) NO982712L (en)
NZ (1) NZ318843A (en)
OA (1) OA10694A (en)
PE (1) PE25698A1 (en)
PL (1) PL197306B1 (en)
RO (1) RO121382B1 (en)
RU (1) RU2160731C2 (en)
SK (1) SK75498A3 (en)
TN (1) TNSN96153A1 (en)
TW (1) TW414787B (en)
UY (1) UY24401A1 (en)
WO (1) WO1997022584A1 (en)
YU (1) YU49486B (en)
ZA (1) ZA9610533B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036405A1 (en) 1998-01-16 1999-07-22 Eisai Co., Ltd. Process for production of donepezil derivative
IL125809A (en) * 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US7148354B2 (en) * 2002-07-24 2006-12-12 Dr. Reddy's Laboratories Limited Process for preparation of donepezil
IL150982A (en) 2002-07-30 2007-02-11 Ori Lerman Process for the preparation of donepezil
IL151253A0 (en) * 2002-08-14 2003-04-10 Finetech Lab Ltd Process for production of highly pure donepezil hydrochloride
US6953856B2 (en) 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
US6649765B1 (en) 2003-02-12 2003-11-18 Usv Limited, Bsd Marg. Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
EP1608371A1 (en) * 2003-03-21 2005-12-28 Ranbaxy Laboratories, Ltd. Process for the preparation of donepezil and derivatives thereof
WO2004099142A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Hydrobromide salt of benzyl-piperidylmethyl-indanone and its polymorphs
AU2003247158A1 (en) 2003-07-01 2005-01-21 Hetero Drugs Limited Preparation of intermediates for acetyl cholinesterase inhibitors
CN1280273C (en) 2003-11-05 2006-10-18 天津和美生物技术有限公司 Synthesis of donepizin and its derivative
JP2008514691A (en) 2004-09-29 2008-05-08 ケマジス リミティド Use of purified donepezil maleate to produce pharmaceutically pure amorphous donepezil hydrochloride
CN100436416C (en) * 2005-07-29 2008-11-26 西南合成制药股份有限公司 Novel donepezil synthesis process
GB0515803D0 (en) 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
AR057910A1 (en) 2005-11-18 2007-12-26 Synthon Bv PROCESS TO PREPARE DONEPEZILO
ES2354737T3 (en) 2006-01-04 2011-03-17 Cipla Limited PROCEDURE AND INTERMEDIATE PRODUCT FOR THE PREPARATION OF DONEPEZYLO.
BRPI0720211A2 (en) * 2006-12-11 2013-12-24 Reviva Pharmaceuticals Inc INDANONE DERIVATIVE, COMPOSITION, AND, USE OF A COMPOSITION
WO2013078608A1 (en) * 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
AU2014307803A1 (en) 2013-08-16 2016-03-10 Universiteit Maastricht Treatment of cognitive impairment with PDE4 inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) * 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
FR2642069B1 (en) * 1989-01-20 1991-04-12 Rhone Poulenc Sante NOVEL BENZOPYRAN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE4439822A1 (en) * 1994-11-08 1996-08-29 Bayer Ag Process for the preparation of benzyl-piperidylmethyl-indanones

Also Published As

Publication number Publication date
PL327512A1 (en) 1998-12-21
AU716462B2 (en) 2000-02-24
DZ2141A1 (en) 2002-07-23
PL197306B1 (en) 2008-03-31
RU2160731C2 (en) 2000-12-20
MX9804820A (en) 1998-10-31
NO982712D0 (en) 1998-06-12
OA10694A (en) 2001-05-04
EP0883607A1 (en) 1998-12-16
PE25698A1 (en) 1998-05-21
AP708A (en) 1998-12-04
GT199600092A (en) 1998-05-12
NO982712L (en) 1998-06-12
RO121382B1 (en) 2007-04-30
AR004368A1 (en) 1998-11-04
HRP960592A2 (en) 1998-06-30
ZA9610533B (en) 1998-06-15
AU7092596A (en) 1997-07-14
JPH11500756A (en) 1999-01-19
YU49486B (en) 2006-08-17
BR9612018A (en) 1999-02-17
TW414787B (en) 2000-12-11
HUP9904275A2 (en) 2000-05-28
SK75498A3 (en) 1999-08-06
UY24401A1 (en) 1997-06-09
MA24032A1 (en) 1997-07-01
YU66096A (en) 1999-11-22
BG102525A (en) 1999-05-31
KR20000064387A (en) 2000-11-06
CA2237647A1 (en) 1997-06-26
TNSN96153A1 (en) 2005-03-15
AP9600892A0 (en) 1997-01-31
IL124452A0 (en) 1998-12-06
IS4752A (en) 1998-05-22
WO1997022584A1 (en) 1997-06-26
HN1996000065A (en) 1997-06-26
IL136420A0 (en) 2001-06-14
CZ180898A3 (en) 1999-05-12
HUP9904275A3 (en) 2001-05-28
JP3066083B2 (en) 2000-07-17
CO4750831A1 (en) 1999-03-31
IL136421A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
NZ318843A (en) Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
ES2000603A6 (en) Process for the preparation of aryl-piperidine carbinols.
AU1433588A (en) 1-phenyl-3-naphthalenyloxypropanamines
ATE201687T1 (en) GALANTHAMIN DERIVATIVE, A METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A MEDICATION
GR3005296T3 (en)
ZA9810320B (en) Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
ES2016017A6 (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives.
NZ233196A (en) Process for preparing glutaric acid derivatives and 2-alkoxycarbonylalkyl cyclohexanone derivatives
PT80787A (en) Process for preparing piperidine (or pyrrolidine)-butanamides and compounds relating to them
NZ333375A (en) A process for the alkylation of alkyl- or benzylcyanogen derivatives in the presence of trialkylamines or -phosphines
HU9701295D0 (en) New process for making intermediers
BG60208B2 (en) Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides
KR0137673B1 (en) Process for preparing sulfonamide derivative of norbornane
NO20000869L (en) Process for Preparation of 1- (Cyclopentenyloxy-4-alkoxyphenyl) -4-oxocyclohexanecarbonitrile

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)